Lv31
310 积分 2025-08-04 加入
A Biopharmaceutical Industry Perspective on the Control of Visible Particles in Biotechnology-Derived Injectable Drug Products
3天前
已完结
In-depth O-glycosylation characterization and comparison of commercially available etanercept biosimilars by using Electron Activated Dissociation
13天前
已完结
In-depth O-glycosylation characterization and comparison of commercially available etanercept biosimilars by using Electron Activated Dissociation
13天前
已完结
Mechanistic insights into inter-chain disulfide bond reduction of IgG1 and IgG4 antibodies
19天前
已完结
An Automated Tool for Glycosimilarity Assessment of mAb Therapeutic Biosimilars: Trastuzumab and Bevacizumab as Case Studies
19天前
已完结
A Novel C-terminal Sequence Variant Discovered in an IgG1 Monoclonal Antibody by LC-MS
20天前
已完结
Cyclization of N-Terminal Glutamic Acid to pyro-Glutamic Acid Impacts Monoclonal Antibody Charge Heterogeneity Despite Its Appearance as a Neutral Transformation
20天前
已完结
The present and future of bispecific antibodies for cancer therapy
20天前
已完结
Structural and Functional Characterization of Disulfide Bond Isomers of Therapeutic Immunoglobulin G2 Antibody
24天前
已完结
Photostability of Topoisomerase I Inhibitor Conjugated IgG1 Antibody–Drug Conjugates: Characterization Study and Degradation Mechanism Analysis
1个月前
已完结
皖公网安备34019202002308
